Calcium mupirocin sprayable formulation
US6426363B1 · kind B1 · utility
1Cited by
9References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 7, 2000 |
| Grant date | Jul 30, 2002 |
| Priority date | — |
| Expiry date | Aug 7, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/351
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mupirocin or a salt or ester thereof may be used to treat recurrent sinusitis and recurrent otitis, in particular with novel spray or cream formulations adapted for administration to the nasopharynx.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.